Anti-SELN/ SELENON/ CFTD functional antibody
Anti-SELN/ SELENON/ CFTD functional antibody for cell culture, ELISA & in-vivo assay
Go to SELENON/SELENON products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1555-Ab-1/ GM-Tg-hg-SE1555-Ab-2 | Anti-Human SELENON monoclonal antibody | Human |
GM-Tg-rg-SE1555-Ab-1/ GM-Tg-rg-SE1555-Ab-2 | Anti-Rat SELENON monoclonal antibody | Rat |
GM-Tg-mg-SE1555-Ab-1/ GM-Tg-mg-SE1555-Ab-2 | Anti-Mouse SELENON monoclonal antibody | Mouse |
GM-Tg-cynog-SE1555-Ab-1/ GM-Tg-cynog-SE1555-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SELENON monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1555-Ab-1/ GM-Tg-felg-SE1555-Ab-2 | Anti-Feline SELENON monoclonal antibody | Feline |
GM-Tg-cang-SE1555-Ab-1/ GM-Tg-cang-SE1555-Ab-2 | Anti-Canine SELENON monoclonal antibody | Canine |
GM-Tg-bovg-SE1555-Ab-1/ GM-Tg-bovg-SE1555-Ab-2 | Anti-Bovine SELENON monoclonal antibody | Bovine |
GM-Tg-equg-SE1555-Ab-1/ GM-Tg-equg-SE1555-Ab-2 | Anti-Equine SELENON monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1555-Ab-1/ GM-Tg-hg-SE1555-Ab-2; GM-Tg-rg-SE1555-Ab-1/ GM-Tg-rg-SE1555-Ab-2; GM-Tg-mg-SE1555-Ab-1/ GM-Tg-mg-SE1555-Ab-2; GM-Tg-cynog-SE1555-Ab-1/ GM-Tg-cynog-SE1555-Ab-2; GM-Tg-felg-SE1555-Ab-1/ GM-Tg-felg-SE1555-Ab-2; GM-Tg-cang-SE1555-Ab-1/ GM-Tg-cang-SE1555-Ab-2; GM-Tg-bovg-SE1555-Ab-1/ GM-Tg-bovg-SE1555-Ab-2; GM-Tg-equg-SE1555-Ab-1/ GM-Tg-equg-SE1555-Ab-2 |
Products Name | Anti-SELENON monoclonal antibody |
Format | mab |
Target Name | SELENON |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SELENON benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1555-Ag-1 | Recombinant multi-species SELN/ SELENON/ CFTD protein |
Target information
Target ID | GM-SE1555 |
Target Name | SELENON |
Gene ID | 57190,74777,362624,719707,612211,101099989,616379,111772406 |
Gene Symbol and Synonyms | 1110019I12Rik,CFTD,CMYP3,MDRS1,RSMD1,RSS,SELENON,SELN,SEPN1 |
Uniprot Accession | Q9NZV5 |
Uniprot Entry Name | SELN_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000162430 |
Target Classification | N/A |
The target: SELENON, gene name: SELENON, also named as CFTD, MDRS1, RSMD1, RSS, SELN, SEPN1. This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.